EMA Authorised: Alprolix (eftrenonacog alfa) — Swedish Orphan Biovitrum AB (publ)

View source ↗

Summary

Authorised status for Alprolix (eftrenonacog alfa) by Swedish Orphan Biovitrum AB, approved for Hemophilia B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia B

Drugs mentioned

• Alprolix (eftrenonacog alfa)

Snippet

Status: Authorised. Therapeutic area: Hemophilia B. MAH: Swedish Orphan Biovitrum AB (publ). Decision date: 04/06/2026. Orphan medicine